10 NORTH HIGH STREET, WEST CHESTER, PA
Reports First Quarter 2026 Financial Results
Annual Report to Security Holders
Reports Fourth Quarter and Full Year 2025 Financial Results
Appointment of Charles Frantzreb as Director of Verrica Pharmaceuticals
Announces Private Placement Financing of $50 Million to Retire Debt and Extend Cash Runway
Financial Results, Press Release
Earnings Release
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
FY 2025
Q3
Q2
Q1
FY 2024
Registration Statement for Securities to be Offered to Employees
Effectiveness Notice
Prospectus filed pursuant to Rule 424(b)(3)
Registration Statement for Securities Offered under a Shelf Registration
Notice of Exempt Offering of Securities
Definitive Proxy Statement
Additional Proxy Materials
PRE 14A
Amended Schedule 13G - Ownership Report
Amended Initial Statement of Beneficial Ownership
Initial Statement of Beneficial Ownership
Amended Schedule 13D - Ownership Report
Statement of Changes in Beneficial Ownership
Definitive Revised Proxy Statement
Correspondence
Submission Upload